Croda International Plc (LON:CRDA - Get Free Report) insider Danuta Gray bought 1,300 shares of the firm's stock in a transaction on Friday, August 1st. The stock was bought at an average cost of GBX 2,600 ($34.57) per share, for a total transaction of £33,800 ($44,940.83).
Croda International Trading Up 2.2%
LON:CRDA traded up GBX 57 ($0.76) during trading hours on Tuesday, reaching GBX 2,647 ($35.19). 313,908 shares of the company were exchanged, compared to its average volume of 1,080,214. Croda International Plc has a 52-week low of GBX 2,527 ($33.60) and a 52-week high of GBX 4,335 ($57.64). The stock has a 50 day simple moving average of GBX 2,958.70 and a 200 day simple moving average of GBX 3,018.67. The firm has a market cap of £3.70 billion, a price-to-earnings ratio of 22.75, a PEG ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25.
Croda International (LON:CRDA - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported GBX 72.20 ($0.96) earnings per share for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. As a group, analysts predict that Croda International Plc will post 181.8307268 EPS for the current year.
Analysts Set New Price Targets
CRDA has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft dropped their price objective on Croda International from GBX 3,400 ($45.21) to GBX 3,000 ($39.89) and set a "hold" rating on the stock in a report on Tuesday, July 29th. Berenberg Bank lowered their price target on Croda International from GBX 3,800 ($50.53) to GBX 3,100 ($41.22) and set a "buy" rating on the stock in a report on Tuesday, July 29th. JPMorgan Chase & Co. upgraded shares of Croda International to an "overweight" rating in a research report on Wednesday, July 30th. Finally, Citigroup reduced their target price on shares of Croda International from GBX 3,550 ($47.20) to GBX 3,300 ($43.88) and set a "neutral" rating for the company in a research note on Tuesday, April 29th.
Check Out Our Latest Analysis on Croda International
Croda International Company Profile
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Read More

Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.